Palliative care in BMT
The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies
Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT
Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?
Early outcomes after allogeneic hematopoietic SCT in pediatric patients with hematologic malignancies following single fraction TBI
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
Prognostic impact of diffuse large B-cell lymphoma subgroups in patients undergoing autologous SCT
Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors
Molecular epidemiological investigation of an outbreak of Pseudomonas aeruginosa infection in an SCT unit
Alefacept treatment for refractory chronic extensive GVHD
Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT
Sezary syndrome in relapse after reduced intensity allogeneic transplant successfully treated with donor lymphocyte infusion